Warning
HTO Nevada Inc. dba Kirkman Recalls MAXIMUM
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0386-2026Drug / Pharmaceutical
HTO Nevada Inc. dba Kirkman Recalls MAXIMUM
HTO Nevada Inc. dba Kirkman · Class II — Moderate Risk
Product Description
MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
Reason for Recall
Stability Data Does Not Support Expiry Date.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide within the U.S
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
HTO Nevada Inc. dba Kirkman has recalled a pharmaceutical product that the FDA classified as Class II affecting 178 bottles. The recall was initiated on February 18, 2026. Stability Data Does Not Support Expiry Date. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.